24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder

Clinical trial NCT00360529 · COMPLETED

Trial details

NCT number: NCT00360529
Sponsor: Sprout Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sexual Dysfunctions, Psychological

Start date: 2006-07-01
Primary completion: 2008-04-01
Enrollment: 880

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.